F-star Therapeutics, Inc. Quarterly Liabilities, Current in USD from Q4 2015 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
F-star Therapeutics, Inc. quarterly Liabilities, Current history and growth rate from Q4 2015 to Q3 2022.
  • F-star Therapeutics, Inc. Liabilities, Current for the quarter ending September 30, 2022 was $14.7M, a 66.1% increase year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $14.7M +$5.84M +66.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $15.3M +$5.36M +53.9% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $12.7M -$1.66M -11.6% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $12.1M -$4.84M -28.5% Dec 31, 2021 10-Q 2022-11-10
Q3 2021 $8.84M +$2.59M +41.5% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $9.95M +$4.82M +93.9% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $14.3M -$10.1M -41.3% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $17M -$12.9M -43.2% Dec 31, 2020 10-K 2022-03-15
Q3 2020 $6.25M +$918K +17.2% Sep 30, 2020 10-Q 2020-11-03
Q2 2020 $5.13M -$109K -2.08% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $24.4M +$20.4M +518% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $29.9M +$25.6M +604% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $5.33M +$213K +4.17% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $5.24M +$967K +22.6% Jun 30, 2019 10-Q 2019-07-31
Q1 2019 $3.95M +$163K +4.31% Mar 31, 2019 10-Q 2019-04-29
Q4 2018 $4.25M -$187K -4.22% Dec 31, 2018 10-K 2020-02-14
Q3 2018 $5.11M +$1.03M +25.2% Sep 30, 2018 10-Q 2018-10-25
Q2 2018 $4.28M +$731K +20.6% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 $3.79M +$970K +34.5% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 $4.43M +$933K +26.7% Dec 31, 2017 10-K 2019-03-11
Q3 2017 $4.09M +$385K +10.4% Sep 30, 2017 10-Q 2017-10-31
Q2 2017 $3.54M -$401K -10.2% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 $2.82M -$357K -11.3% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 $3.5M -$45K -1.27% Dec 31, 2016 10-K 2018-02-20
Q3 2016 $3.7M Sep 30, 2016 10-Q 2016-10-28
Q2 2016 $3.95M Jun 30, 2016 10-Q 2016-08-01
Q1 2016 $3.17M Mar 31, 2016 10-Q 2016-06-15
Q4 2015 $3.55M Dec 31, 2015 10-K 2017-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.